DRUG NEWS: Ximelagatran works as well as warfarin

$3.95
Nursing2014
February 2004 
Volume 34  Number 2
Pages 24 - 24
 
  PDF Version Available!

ABSTRACT
© 2004 Lippincott Williams & Wilkins, Inc. Volume 34(2)             February 2004             p 24 Ximelagatran works as well as warfarin [DRUG NEWS: ATRIAL FIBRILLATION]

The oral thrombin inhibitor ximelagatran (Exanta), which isn't yet available in the United States, is as effective as warfarin (Coumadin) for preventing strokes and reducing embolic events in patients with nonvalvular atrial fibrillation.

Researchers randomly assigned almost 4,000 high-risk patients to receive either ximelagatran or warfarin. Because warfarin can be hard to maintain in the therapeutic range, researchers monitored coagulation studies in patients taking it very closely. As a result, patients taking warfarin remained in the therapeutic range nearly 70% of the time. To ensure that all patients remained in the dark about the drug they were taking, researchers also administered tests and fake “drug adjustments” ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!


Cost:$3.95
1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Password


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.


Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.






jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events